This study aims to compare the real-world effectiveness of single-dose FDI versus combined intravenous and oral iron treatment in improving hemoglobin (Hb) levels among postpartum women with anemia caused by PPH. This evidence concerns the gene GSTM1 and anemia (phenotype).